Clinical Research in Cardiology

, Volume 100, Issue 9, pp 781–788 | Cite as

Vitamin D deficiency is an independent predictor of anemia in end-stage heart failure

  • Armin Zittermann
  • Antje Jungvogel
  • Sylvana Prokop
  • Joachim Kuhn
  • Jens Dreier
  • Uwe Fuchs
  • Uwe Schulz
  • Jan F. Gummert
  • Jochen Börgermann
Original Paper

Abstract

Both, anemia and vitamin D deficiency are prevalent in patients with heart failure. According to recent evidence, vitamin D may stimulate erythropoiesis. We measured circulating 25-hydroxyvitamin D (25[OH]D), 1,25-dihydroxyvitamin D (1,25[OH]2D) and hemoglobin (Hb) in a cross-sectional study in 364 end-stage heart failure patients awaiting cardiac transplantation, of whom 52.6% met the criteria for anemia (Hb < 13 g/dl in males and <12 g/dl in females). None of the patients were on erythrocyte-stimulating agents. Of the study cohort, 87.8% had 25(OH)D concentrations below 50 nmol/l. The mean Hb concentrations were significantly reduced in the lower tertiles of 25(OH)D and 1,25(OH)2D (P < 0.001). In multivariate-adjusted logistic regression analyses, the odds ratios for anemia of the lowest tertile of 25(OH)D (<18 nmol/l) and 1,25(OH)2D (<40 pmol/l) were 2.69 (1.46–5.00) and 4.08 (2.18–7.62) compared with their respective highest tertile (>32 nmol/l and >70 pmol/l). Patients with severe dual deficiency of 25(OH)D and 1,25(OH)2D had an odds ratio for anemia of 9.87 (95% CI 3.59–27.1) compared with patients in the highest tertile for both vitamin D metabolites. Circulating 1,25(OH)2D was directly related to circulating 25(OH)D levels and kidney function (P < 0.001), and inversely associated with C-reactive protein (P = 0.020).

Our data demonstrate that vitamin D deficiency is independently associated with low Hb values and anemia in end-stage heart failure. Circulating 1,25(OH)2D is a better predictor of anemia than circulating 25(OH)D. Prospective randomized studies with administration of vitamin D (metabolites) will have to clarify if the association of vitamin D deficiency with anemia is causal.

Keywords

Heart failure Anemia Vitamin D Erythropoiesis Hemoglobin 25-hydroxyvitamin D 1,25-dihydroxyvitamin D 

References

  1. 1.
    Tang WH, Mullens W (2010) Cardiorenal syndrome in decompensated heart failure. Heart 96:255–260PubMedCrossRefGoogle Scholar
  2. 2.
    Yndestad A, Damas JK, Oie E, Ueland T, Gullestad L, Aukrust P (2006) Systemic inflammation in heart failure—the whys and whereofes. Heart Fail Rev 11:83–92PubMedCrossRefGoogle Scholar
  3. 3.
    Strassburg S, Anker SD (2006) Metabolic and immunologic derangements in chronic cardiac cachexia: where to from here? Hear Fail Rev 11:64–65Google Scholar
  4. 4.
    Silverberg DS (2010) The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome. Heart Fail Rev. doi: 10.1007/s10741-010-9194-2
  5. 5.
    Alon DB, Chaimovitz C, Dvilansky A, Lugassy G, Douvdevani A, Shany S, Nathan I (2002) Novel role of 1, 25(OH)(2)D(3) in induction of erythroid progenitor cell proliferation. Exp Hematol 30:403–409PubMedCrossRefGoogle Scholar
  6. 6.
    Aucella F, Scalzulli RP, Gatta G, Vigilante M, Carella AM, Stallone C (2003) Calcitriol increases burst-forming unit-erythroid proliferation in chronic renal failure. A synergistic effect with r-HuEpo. Nephron Clin Pract 95:c121–c127PubMedCrossRefGoogle Scholar
  7. 7.
    Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281PubMedCrossRefGoogle Scholar
  8. 8.
    Zittermann A, Schleithoff SS, Koerfer R (2006) Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev 11:25–33PubMedCrossRefGoogle Scholar
  9. 9.
    Zittermann A (2006) Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 92:39–48PubMedCrossRefGoogle Scholar
  10. 10.
    Patel NM, Gutiérrez OM, Andress DL, Coyne DW, Levin A, Wolf M (2010) Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int 77:715–720PubMedCrossRefGoogle Scholar
  11. 11.
    Grindulis H, Scott PH, Belton NR, Wharton BA (1986) Combined deficiency of iron and vitamin D in Asian toddlers. Arch Dis Child 61:843–848PubMedCrossRefGoogle Scholar
  12. 12.
    Lawson M, Thomas M (1999) Vitamin D concentrations in Asian children aged 2 years living in England: population survey. BMJ 318:28PubMedGoogle Scholar
  13. 13.
    Mehta S, Giovannucci E, Mugusi FM, Spiegelman D, Aboud S, Hertzmark E, Msamanga GI, Hunter D, Fawzi WW (2010) Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One 5:e8770PubMedCrossRefGoogle Scholar
  14. 14.
    Goicoechea M, Vazquez MI, Ruiz MA, Gomez-Campdera F, Perez-García R, Valderrábano F (1998) Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron 78:23–27PubMedCrossRefGoogle Scholar
  15. 15.
    Neves PL, Triviño J, Casaubon F, Santos V, Mendes P, Romão P, Bexiga I, Bernardo I (2006) Elderly patients on chronic hemodialysis with hyperparathyroidism: increase of hemoglobin level after intravenous calcitriol. Int Urol Nephrol 38:175–177PubMedCrossRefGoogle Scholar
  16. 16.
    Rick W (1977) Klinische Chemie und Mikroskopie, 5th edn. Springer, BerlinGoogle Scholar
  17. 17.
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMedGoogle Scholar
  18. 18.
    Zittermann A, Schleithoff SS, Frisch S, Götting C, Kuhn J, Koertke H, Kleesiek K, Tenderich G, Koerfer R (2009) Circulating calcitriol concentrations and total mortality. Clin Chem 55:1163–1170PubMedCrossRefGoogle Scholar
  19. 19.
    Sim JJ, Lac PT, Liu IL, Meguerditchian SO, Kumar VA, Kujubu DA, Rasgon SA (2010) Vitamin D deficiency and anemia: a cross-sectional study. Ann Hematol 89:447–452PubMedCrossRefGoogle Scholar
  20. 20.
    Desai A, Lewis E, Solomon S, McMurray JJV, Pfeffer M (2010) Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis. Eur Heart J 12:936–942CrossRefGoogle Scholar
  21. 21.
    Cleland JG, Sullivan JT, Ball S, Horowitz JD, Agoram B, Rosser D, Yates W, Tin L, Fuentealba P, Burton PB (2005) Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia: a pharmacokinetic and pharmacodynamic investigation. J Cardiovasc Pharmacol 46:155–161PubMedCrossRefGoogle Scholar
  22. 22.
    Ponikowski P, Anker SD, Szachniewicz J, Okonko D, Ledwidge M, Zymlinski R, Ryan E, Wasserman SM, Baker N, Rosser D, Rosen SD, Poole-Wilson PA, Banasiak W, Coats AJ, McDonald K (2007) Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 49:753–762PubMedCrossRefGoogle Scholar
  23. 23.
    van Veldhuisen DJ, Dickstein K, Cohen-Solal A, Lok DJ, Wasserman SM, Baker N, Rosser D, Cleland JG, Ponikowski P (2007) Randomized, double-blind, placebocontrolled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. Eur Heart J 28:2208–2216PubMedCrossRefGoogle Scholar
  24. 24.
    Ghali JK, Anand IS, Abraham WT, Fonarow GC, Greenberg B, Krum H, Massie BM, Wasserman SM, Trotman ML, Sun Y, Knusel B, Armstrong P (2008) Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation 117:526–535PubMedCrossRefGoogle Scholar
  25. 25.
    Parissis JT, Kourea K, Panou F, Farmakis D, Paraskevaidis I, Ikonomidis I, Filippatos G, Kremastinos DT (2008) Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am Heart J 155:e751–e757CrossRefGoogle Scholar
  26. 26.
    Parissis JT, Kourea K, Andreadou I, Ikonomidis I, Markantonis S, Ioannidis K, Paraskevaidis I, Iliodromitis E, Filippatos G, Kremastinos DT (2009) Effects of Darbepoetin Alfa on plasma mediators of oxidative and nitrosative stress in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 103:1134–1138PubMedCrossRefGoogle Scholar
  27. 27.
    Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill J, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R, Uno H (2009) Baseline characteristics in the trial to reduce cardiovascular events with aranesp therapy (TREAT). Am J Kidney Dis 54:59–69PubMedCrossRefGoogle Scholar
  28. 28.
    Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, Schwartz D, Yachnin T, Steinbruch S, Shapira I, Laniado S, Iaina A (2001) The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 37:1775–1780PubMedCrossRefGoogle Scholar
  29. 29.
    Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne AS (2003) Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107:294–299PubMedCrossRefGoogle Scholar
  30. 30.
    Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabro A, Campagna SM, Nuti R (2006) Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J 152:1096–1099PubMedCrossRefGoogle Scholar
  31. 31.
    Palazzuoli A, Silverberg DS, Calabro A, Spinelli T, Quatrini I, Campagna MS, Franci B, Nuti R (2009) Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia. J Cardiovasc Pharmacol 53:462–467PubMedCrossRefGoogle Scholar
  32. 32.
    Kumar VA, Kujubu DA, Sim JJ, Rasgon SA, Yang PS (2010) Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. J Nephrol. A8172D7C-BB3E-4513-9402-C7FEFA25E4D7[pii]Google Scholar
  33. 33.
    Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229–238PubMedGoogle Scholar
  34. 34.
    Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC (2005) Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin angiotensin systems. Am J Physiol Endocrinol Metabol 288:E125–E132CrossRefGoogle Scholar
  35. 35.
    Simpson RU, Hershey SH, Nibbelink KA (2007) Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 103:521–524PubMedCrossRefGoogle Scholar
  36. 36.
    Kosiborod M, Curtis JP, Wang Y, Smith GL, Masoudi FA, Foody JM, Havranek EP, Krumholz HM (2005) Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med 165:2237–2244PubMedCrossRefGoogle Scholar
  37. 37.
    Zitermann A, Schulze Schleithoff S, Tenderich G, Berthold HK, Körfer R, Stehle P (2003) Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41:105–112CrossRefGoogle Scholar
  38. 38.
    Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO, Dobnig H (2008) Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 93:3927–3935PubMedCrossRefGoogle Scholar
  39. 39.
    Zittermann A, Schleithoff SS, Götting C, Fuchs U, Kuhn J, Wlost S, Kleesiek K, Tenderich G, Koerfer R (2009) Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation 87:118–124PubMedCrossRefGoogle Scholar
  40. 40.
    Mahfoud F, Kindermann I, Kindermann M, Ukena C, Böhm M (2009) Comorbidity: anemia and heart failure. Dtsch Med Wochenschr 134:825–830 (in German)PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Armin Zittermann
    • 1
  • Antje Jungvogel
    • 1
  • Sylvana Prokop
    • 1
  • Joachim Kuhn
    • 2
  • Jens Dreier
    • 2
  • Uwe Fuchs
    • 1
  • Uwe Schulz
    • 1
  • Jan F. Gummert
    • 1
  • Jochen Börgermann
    • 1
  1. 1.Department of Cardio-Thoracic Surgery, Heart Center North Rhine-WestphaliaRuhr University BochumBad OeynhausenGermany
  2. 2.Institute for Laboratory and Transfusion Medicine, Heart Center North Rhine-WestphaliaRuhr University BochumBad OeynhausenGermany

Personalised recommendations